FRESENIUS-KABI PHARMA PORTUGAL, LDA secures contract for Call For Proposals Under Framework Agreement(S) 1077/2024 - Miscellaneous Medicines (Ii); 900/2024 - Antiretroviral Medicines For The Treatment Of Hiv Infection; 780/2024 -M

Portugal, Oct. 14 -- Portugal based FRESENIUS-KABI PHARMA PORTUGAL, LDA has secured contract from Instituto Portugues De Oncologia De Lisboa Fg, E.P.E. for Call For Proposals Under Framework Agreement(S) 1077/2024 - Miscellaneous Medicines (Ii); 900/2024 - Antiretroviral Medicines For The Treatment Of Hiv Infection; 780/2024 -M. The value of the contract is worth 583520 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....